Delivery Order SPE2DR25D3101-SPE2DR26F5S83
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $16,237.23 under a firm fixed-price contract. This non-competitive delivery order is scheduled for completion by December 5, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen was selected to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed price contract with a ceiling value of $33,236.96. This non-set-aside competitive award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, non-set-aside contract is valued at $1,807.80 and utilizes firm fixed price terms. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office and primary distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Jardiance 25 mg tablets in quantities of 90 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $94,228.99 and is scheduled for completion by August 12, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $13,245.31. This firm fixed-price delivery order, with an ultimate completion date of December 2, 2025, represents a competitively awarded, non-set-aside contract. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $17,796.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $33,218.01 and an ultimate completion date of November 7, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $55,533.83. This firm fixed-price delivery order, which is expected to be completed by November 26, 2025, represents a non-competitive set-aside procurement supporting federal pharmaceutical supply needs. The contract is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Jardiance 10 mg tablets in a 90-count package, with a ceiling value of $5,192.09 and a firm fixed price structure. The delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The ultimate completion date...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Jardiance 25 mg tablets (90-count packaging) valued at $6,733.04 under a firm fixed-price contract. This non-set-aside delivery order is scheduled for completion by October 24, 2025, and will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order against AmerisourceBergen's larger Indefinite...
- SPE2DR25D3101Indefinite Delivery Contract
- SPE2DR25D3101-SPE2DR26F5S83Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 4,570,268,300 units of Jardiance 25 mg tablets (90-count packages) under a firm fixed-price contract. The award, made on December 12, 2025, carries a ceiling value of $4,324.62 and is scheduled for ultimate completion by December 15, 2025. This is a non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9 billion prime vendor agreement (designated SPE2DX) running through December 2026. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, one of the nation's major pharmaceutical distributors, serves as a critical vendor in the federal medical supply chain, particularly for military and veteran healthcare systems. Jardiance, a brand-name diabetes medication, represents one of many pharmaceutical products the company supplies through its extensive federal contract portfolio with DLA. The delivery order demonstrates AmerisourceBergen's ongoing role as a key supplier within the DLA's global pharmaceutical support network, which enables the company to deliver a comprehensive range of medications and medical supplies to support defense health operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 12/11/25 |